Metagenomi inks $175m Series B
Metagenomi, a genetic medicines company, has raised $175 million in Series B financing.
Metagenomi, a genetic medicines company, has raised $175 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination